To speak with a nurse or find a surgeon call 888-689-5277 or visit [ Ссылка ]

Learn more about the sacroiliac joint at [ Ссылка ].

In a classic study, over 22% of patients with low back pain were found to have the SI joint and SI joint dysfunction as either the primary source of pain or a component of their low back pain.

Based on very rigorously reviewed research there are five provocation tests that are used to commonly diagnose SI joint disorders. These five tests, when used in combination, can be very accurate, both sensitive and specific, when giving information about the potential effectiveness of an injection into the joint.

The SI joint should be considered a potential pain generator and option for treatment in every case with low back pain.

The diagnosis of SI joint disorders or at least the provocation tests should be included in every patient when they come in the door.

Biagio Mazza, PT - paid consultant of SI-BONE

It is commonly reported in clinical literature that up to 25% of low back pain is caused by the SI joint. Once non-surgical treatment options have been tried and do not provide relief, your surgeon may consider other options, including surgery.

SI-BONE, Inc. has developed a minimally invasive surgical (MIS), innovative, patented, implant system to treat certain sacroiliac (SI) joint problems. The iFuse Implant System® consists of titanium implants and associated surgical instruments.

The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months.

There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For information about the risks, visit: www.si-bone.com/risks

U.S. Patent Nos. 8,202,305; 8,840,623; 8,986,348; and 9,039,743; pending U.S. and foreign patent applications.

(C) 2012. SI-BONE, Inc. All rights reserved.SI-BONE and iFuse Implant System are registered trademarks of SI-BONE, Inc.

свернуть